Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place
2014 PLURISTEM THERAPEUTICS, INC. Annual Meeting of StockholdersMEETING DATE: May 22, 2014For Holders as of: March 26, 2014